← Evidence map

ArticleThe New England journal of medicine2019

Teplizumab in Relatives at Risk for Type 1 Diabetes. Reply.

Kevan C Herold et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

16 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 31693818